SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-14-058266
Filing Date
2014-08-07
Accepted
2014-08-07 16:09:26
Documents
10
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a14-18037_110q.htm 10-Q 1064949
2 EX-31.1 a14-18037_1ex31d1.htm EX-31.1 12757
3 EX-31.2 a14-18037_1ex31d2.htm EX-31.2 12601
4 EX-32.1 a14-18037_1ex32d1.htm EX-32.1 7649
  Complete submission text file 0001104659-14-058266.txt   5964207

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT nerv-20140630.xml EX-101.INS 590269
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nerv-20140630.xsd EX-101.SCH 46142
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT nerv-20140630_cal.xml EX-101.CAL 43562
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT nerv-20140630_def.xml EX-101.DEF 269555
9 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT nerv-20140630_lab.xml EX-101.LAB 692547
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nerv-20140630_pre.xml EX-101.PRE 394098
Mailing Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142
Business Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142 617-444-8444
Minerva Neurosciences, Inc. (Filer) CIK: 0001598646 (see all company filings)

IRS No.: 260784194 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36517 | Film No.: 141023954
SIC: 2834 Pharmaceutical Preparations